Methods and Designs of Modern Breast Cancer Confirmatory Trials

SIMPLE SUMMARY: The benefit–risk assessments of new drugs for breast cancer (BC) face several challenges, as all stakeholders do not agree on the evidence bar required for market authorization, and by the fragmentation of breast cancer diagnosis. In this study, we describe the methods and designs of...

Descripción completa

Detalles Bibliográficos
Autores principales: Péron, Julien, Reverdy, Thibaut, Smenteck, Colette, Cortet, Marion, You, Benoît, Freyer, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199547/
https://www.ncbi.nlm.nih.gov/pubmed/34199352
http://dx.doi.org/10.3390/cancers13112757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199547/
https://www.ncbi.nlm.nih.gov/pubmed/34199352
http://dx.doi.org/10.3390/cancers13112757

Ejemplares similares